Merck, Daiichi post mid-stage data for novel lung cancer drug Source: Seekingalpha
Browsing: lung
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Sundry Photography/iStock Editorial through Getty Images Merck (NYSE:MRK) has acquired approval from the European Commission for its drug Winrevair (sotatercept), for use together with different pulmonary…
Sundry Photography/iStock Editorial by way of Getty Images Merck (NYSE:MRK) has obtained approval from the European Commission for its drug Winrevair (sotatercept), for use together with…
Sundry Photography/iStock Editorial by way of Getty Images Merck (NYSE:MRK) has obtained approval from the European Commission for its drug Winrevair (sotatercept), for use together with…
